Marker Therapeutics Inc (MRKR) Live Share Price, Invest From India

Marker Therapeutics Inc Stock Performance

as on April 25, 2026 at 2:13 am IST

Day's Low
Day's High
$1.36
Day's Price Range
$1.46
$1.41
3.55%
Downside
3.55%
Upside
52 Week's Low
52 Week's High
$0.81
52-Week Price Range
$4.07
$1.41
42.56%
Downside
188.65%
Upside

Marker Therapeutics Inc share price movements today

Previous Close: $1.45
Open: $1.46
Volume: 283.3K
Day's Low - High: $1.36 - $1.46
52 Week Low - High: $0.81 - $4.07

Marker Therapeutics Inc Historical Returns

1 Month Return: + 15.08 %
3 Month Return: -30.95 %
1 Year Return: + 14.17 %
3 Year Return: + 57.61 %
5 Year Return: -93.61 %

Marker Therapeutics Inc Stock Fundamentals & Key Indicators

Check Marker Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$24.2M

EPS (TTM)

-0.61

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-11.8M

Revenue (TTM)

3.5M

Profit Margin

0.00%

Return On Equity TTM

-68.81%

Marker Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Marker Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Marker Therapeutics Inc	BUY	$24.2M	-93.61%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.4B	129.51%	133.3	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.3B	99.68%	28.57	32.94%
BeiGene, Ltd.	NA	$33.3B	NA	121.87	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	56.77%	17.99	31.41%

Stock Returns calculator for Marker Therapeutics Inc Stock including INR - Dollar returns

The Marker Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Marker Therapeutics Inc investment value today

Current value as on today

₹1,22,607

Returns

₹22,607

(+22.61%)

Returns from Marker Therapeutics Inc Stock

₹11,024 (+11.02%)

Dollar Impact

₹11,584 (+11.58%)

Analyst Recommendation on Marker Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Marker Therapeutics Inc. Average target price of $7.87

Marker Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Marker Therapeutics Inc.

What analysts predicted

82.08%UPSIDE

Target Price

$7.87

Current Price

$1.41

Analyzed by

7 Analysts

Target

$7.87

Marker Therapeutics Inc target price $7.87, a slight upside of 82.08% compared to current price of $1.41. According to 7 analysts rating.

Marker Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Marker Therapeutics Inc Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 25, 2026 to April 24, 2026

Change:28% versus previous 30 day period

Marker Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	1	1	1	1	2	0	0	1	1
Gross Profit	-1	-1	-1	-1	-1	-2	-2	-3	1	-
Operating Income	-3	-2	-2	-2	-2	-3	-4	-4	-2	-1
EBITDA	-2	-2	-2	-2	-2	-3	-4	-4	-1	-1
Interest Expense	-	0	-	-	-	0	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-2	-2	-2	-2	-3	-4	-4	-1	-1
Income Tax Expense	0	0	-2	-	-	0	-	-	-	0
Net Income	-2	-2	-2	-2	-2	-3	-4	-4	-1	-1
Net Profit Margin	-1157.57%	-265.31%	-192.34%	-187.53%	-119.83%	-170.43%	-1273.60%	-466.28%	-162.11%	-154.35%

Marker Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	0	0	1	3	3	6	3
Gross Profit	-	-5	-123	-12	-18	-1	-8	-7	-6	-
Operating Income	-8	-11	-148	-22	-28	-39	-19	-14	-11	-12
EBITDA	6	-11	-147	-22	-27	-38	-17	-11	-11	-12
Interest Expense	-	-	-	-	0	0	0	-	-	-
Depreciation	-	-	-	0	1	3	3	-	-	-
Income Before Tax	-2	-10	-147	-21	-28	-41	-19	-14	-10	-12
Income Tax Expense	-6	0	0	-1	0	0	0	0	0	0
Net Income	-2	-10	-147	-21	-28	-41	-29	-8	-10	-12
Net Profit Margin	0.00%	-5998.99%	-71826.36%	-10050.92%	-6149.73%	-3372.68%	-851.87%	-248.76%	-162.82%	-342.96%

Marker Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	-2	-2	-2	-3	-4	-4	-1	-12,163,609
Operating Cash Flow	-2	-3	-3	1	-4	-5	-1	-2	-12,014,070
Investing Cash Flow	-18	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	14	0	0	9	9,864,478
Change in Cash	-2	-3	-3	1	10	-5	-1	7	17,042,828

Marker Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-10	-147	-21	-28	-41	-19	-14	-10	-12,163,620
Operating Cash Flow	-8	-14	-18	-20	-27	-26	-16	-10	-12,014,081
Investing Cash Flow	0	0	0	-9	-3	-4	18	-	-
Financing Cash Flow	5	71	0	6	52	0	1	14	9,864,488
Change in Cash	-2	56	-17	-22	22	-31	3	4	-2,149,593

Global Institutional Holdings in Marker Therapeutics Inc

Funds	Holdings
Geode Capital Management, LLC	0.78%
Geode Capital Management, LLC	0.58%
Alyeska Investment Group, L.P.	1.65%
Renaissance Technologies Corp	0.74%
TWO SIGMA SECURITIES, LLC	0.29%

See all

Marker Therapeutics Inc News & Key Events

Insights on Marker Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MRKR has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -4.44M → -1.70M (in $), with an average increase of 43.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.3% return, outperforming this stock by 15.1%
NEGATIVE IMPACT
Price Dip
In the last 7 days, MRKR stock has moved down by -12.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.23M → 1.10M (in $), with an average decrease of 10.5% per quarter

About Marker Therapeutics Inc

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.

Organisation	Marker Therapeutics Inc
Headquarters	2450 Holcombe Blvd, Houston, TX, United States, 77021
Industry	Biotechnology
CEO	Dr. Juan F. Vera M.D.
E-voting on shares	Click here to vote

Key Management of Marker Therapeutics Inc

Name	Title
Dr. Juan F. Vera M.D.	Co-Founder, CEO, President, Treasurer, Secretary & Director
Ms. Elizabeth Donnelly	Director of Administration
Dr. Maria-Bernadette Madel Ph.D.	Director of Corporate Operations & External Communications
Mr. Edmund Cheung	Vice President of Human Resources
Patricia Allison	Head of Clinical Operations
Ms. Mary Newman Ph.D.	Head of Regulatory Affairs
Dr. Robert Z. Florkiewicz Sr., Ph.D.	Senior Director of Molecular Biology & Virology

FAQs

What is Marker Therapeutics Inc share price today?

Marker Therapeutics Inc share price today is $1.41 as on April 24, 2026 at 8:43 pm IST. Marker Therapeutics Inc share today touched a day high of $1.46 and a low of $1.36.

What is the 52 week high and 52 week low for Marker Therapeutics Inc share?

Marker Therapeutics Inc share touched a 52 week high of $4.07 on July 17, 2025 and a 52 week low of $0.81 on August 28, 2025. Marker Therapeutics Inc stock price today i.e. April 24, 2026 at 8:43 pm IST is trending at $1.41,which is 65.36% down from its 52 week high and 74.10% up from its 52 week low.

What is Marker Therapeutics Inc's market capitalisation today?

Marker Therapeutics Inc market capitalisation is $0.00T as on April 24, 2026 at 8:43 pm IST.

How to invest in Marker Therapeutics Inc Stock (MRKR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Marker Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Marker Therapeutics Inc Shares that will get you 1.0638 shares as per Marker Therapeutics Inc share price of $1.41 per share as on April 24, 2026 at 8:43 pm IST.

What is the minimum amount required to buy Marker Therapeutics Inc Stock (MRKR) from India?

Indian investors can start investing in Marker Therapeutics Inc (MRKR) shares with as little as ₹94.228 or $1 (as of April 24, 2026 at 8:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Marker Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on April 24, 2026 at 8:44 pm IST). Based on Marker Therapeutics Inc share’s latest price of $1.41 as on April 24, 2026 at 8:43 pm IST, you will get 7.0922 shares of Marker Therapeutics Inc. Learn more about fractional shares .

What are the returns that Marker Therapeutics Inc has given to Indian investors in the last 5 years?

Marker Therapeutics Inc stock has given -93.61% share price returns and 25.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?